Promopharm
A Santé stock listed on the Casablanca Stock Exchange.
What does Promopharm do?
Société de Promotion Pharmaceutique du Maghreb (Promopharm) is a Moroccan pharmaceutical laboratory that manufactures and markets generic medicines, parapharmaceutical products and dermocosmetics. It is the Moroccan entity of the Hikma pharmaceutical group, its majority shareholder.
Source: company official website
Promopharm performance
Stock performance over the main periods. Price as of July 16, 2026. Click a period to update the chart.
As of July 16, 2026, Promopharm trades at 1,345.00 MAD, down 10.3% year to date.
Promopharm ratios
Valuation and profitability ratios, as of July 15, 2026.
Ratios computed from the share price and the latest published financial statements.
The funds that own Promopharm
6 Moroccan funds own Promopharm, for 11.2 M MAD of combined assets, 0.8% of market cap. As of the latest published inventory (December 31, 2025).
The list of owning funds
The breakdown of the 6 owning funds and the stock's weight in each portfolio is for subscribers.
Detailed financial analysis of Promopharm
Margins, EV/EBITDA, leverage, sector KPIs and earnings history, for subscribers.
Frequently asked questions about Promopharm
Data updated automatically · last update: July 16, 2026
Analyze Promopharm and the whole Casablanca market
Price, ratios, earnings, fund ownership and comparator, with a Yuna subscription.